EMPIRE CONSULTING GROUP

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Biotechnology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 18, 2026

Bills named in this filing 1

Lobbying activity 1

Health Issues

HR 1227, Alternatives to PAIN Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.